Accessibility Menu
Arrow-Thin-Down
S&P 500
7,412.87
+0.2%
+13.94
Arrow-Thin-Down
DJI
49,704.34
+0.2%
+95.18
Arrow-Thin-Down
NASDAQ
26,274.13
+0.1%
+27.05
Arrow-Thin-Down
Bitcoin
$81,978.00
+0.7%
+$597.00
Arrow-Thin-Down
AAPL
$292.54
-0.2%
-$0.51
Arrow-Thin-Down
AMZN
$268.77
-1.4%
-$3.91
Arrow-Thin-Down
GOOG
$386.63
-2.6%
-$10.42
Arrow-Thin-Down
META
$598.72
-1.8%
-$10.91
Arrow-Thin-Down
MSFT
$412.31
-0.7%
-$2.81
Arrow-Thin-Down
NVDA
$219.28
+1.9%
+$4.08
Arrow-Thin-Down
TSLA
$444.94
+3.9%
+$16.59
Most Active StocksDaily Stock GainersDaily Stock Losers
Idexx Laboratories logo

Idexx Laboratories

(NASDAQ) IDXX

Current Price$531.85
Market Cap$44.18B
Since IPO (1991)+59,151%
5 Year+3%
1 Year+14%
1 Month-5%

Idexx Laboratories Financials at a Glance

Market Cap

$44.18B

Revenue (TTM)

$4.45B

Net Income (TTM)

$1.10B

EPS (TTM)

$13.59

P/E Ratio

41.21

Dividend

$0.00

Beta (Volatility)

1.18 (Average)

Price

$531.85

Volume

62,525

Open

$558.32

Previous Close

$531.85

Daily Range

$524.58 - $559.84

52-Week Range

$496.61 - $769.98

IDXX News

Boy holds up globe in green field.

10 Best ESG Investing Stocks to Buy in 2026

Jeremy BowmanMar 11, 2026
GettyImages-1553902230

Got $5,000? Here's the Ultimate Pick-and-Shovel Pet Stock (Spoiler: It's Not Chewy)

Josh Kohn-LindquistFeb 20, 2026
Dog looking at camera with its mouth open

Why Idexx Laboratories Stock Surged by Almost 15% Today

Eric VolkmanNov 3, 2025
GettyImages-1516239450 (1).jpg

Seilern Investment Management Sells $43 Million Worth of IDEXX Laboratories (NASDAQ: IDXX) Stock

Josh Kohn-LindquistOct 14, 2025
investor in business attire reviews information on a tablet

These Were the 5 Top-Performing Stocks in the S&P 500 in August 2025

Jon QuastSep 4, 2025
Foolcom-Featured.png

Idexx (IDXX) Q2 Revenue Jumps 11%

Motley Fool Markets TeamAug 4, 2025
GettyImages-1553902230 (1)

Meet the Little-Known S&P 500 Stock That Has Rocketed 10,230% Higher Since 2000

Josh Kohn-LindquistMar 29, 2025
GettyImages-1725491683 (1)

Why Idexx Labs Stock Rocketed Higher This Week

Josh Kohn-LindquistFeb 7, 2025
Page 1

IDXX: Motley Fool Moneyball Superscore

81

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Idexx Laboratories

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

11,000

CEO

Jonathan J. Mazelsky, MBA

Website

www.idexx.com

Headquarters

Westbrook, ME 04092, US

IDXX Financials

Key Financial Metrics (TTM)

Gross Margin

62%

Operating Margin

32%

Net Income Margin

25%

Return on Equity

73%

Return on Capital

67%

Return on Assets

32%

Earnings Yield

2.43%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$44.18B

Shares Outstanding

78.88M

Volume

62.52K

Avg. Volume

534.85K

Financials (TTM)

Gross Profit

$2.66B

Operating Income

$1.36B

EBITDA

$1.47B

Operating Cash Flow

$1.18B

Capital Expenditure

$124.68M

Free Cash Flow

$1.05B

Cash & ST Invst.

$180.07M

Total Debt

$1.08B

Idexx Laboratories Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$1.14B

+14.3%

Gross Profit

$722.74M

+15.9%

Gross Margin

63.35%

N/A

Market Cap

$44.18B

N/A

Market Cap/Employee

$4.02M

N/A

Employees

11,000

N/A

Net Income

$278.45M

+14.7%

EBITDA

$362.59M

+3.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$878.07M

+1.9%

Accounts Receivable

$603.54M

-0.1%

Inventory

$382.40M

-3.4%

Long Term Debt

$398.60M

-27.1%

Short Term Debt

$680.00M

+32.7%

Return on Assets

32.35%

N/A

Return on Invested Capital

67.42%

N/A

Free Cash Flow

$0.00

-100.0%

Operating Cash Flow

$0.00

-100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EWEdwards Lifesciences Corporation
$77.17-3.50%
CAHCardinal Health, Inc.
$182.58-0.58%
ARGXargenx SE
$813.28+3.98%
ALNYAlnylam Pharmaceuticals, Inc.
$284.84-3.46%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$42.40-0.00%
TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF
$6.82-0.09%
MARAMara Holdings
$13.53+0.05%
NOKNokia
$13.89+0.08%

Questions About IDXX

What is the current price of Idexx Laboratories?

Idexx Laboratories is trading at $531.85 per share.

What is the 52-week range for Idexx Laboratories?

Over the past 52 weeks, Idexx Laboratories has traded between $496.61 and $769.98.

How much debt does Idexx Laboratories have?

As of the most recent reporting period, Idexx Laboratories reported total debt of $1.11B.

How much cash does Idexx Laboratories have on hand?

Idexx Laboratories reported $200.53M in cash and cash equivalents in its most recent financial results.

What is Idexx Laboratories’s dividend yield?

Idexx Laboratories does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services